Choline kinase inhibitors synergize with TRAIL in the treatment of colorectal tumors and overcomes TRAIL resistance
Aim: The aim of this study was to investigate the effects of the combination of choline kinase inhibitor MN58b and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) against colon cancer cells. Methods: TRAIL-sensitive (DLD-1) and TRAIL-resistant (SW620) cells were treated with MN58b an...
Main Authors: | Juan Carlos Lacal, Ladislav Andera |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Cancer Translational Medicine |
Subjects: | |
Online Access: | http://www.cancertm.com/article.asp?issn=2395-3977;year=2016;volume=2;issue=6;spage=163;epage=174;aulast=Lacal |
Similar Items
-
Piperlongumine inhibits cell growth and enhances TRAIL-induced apoptosis in prostate cancer cells
by: Gorkem Kismali, et al.
Published: (2020-01-01) -
Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis
by: Ruo-Jing Wei, et al.
Published: (2018-01-01) -
Chalcones Enhance TRAIL-Induced Apoptosis in Prostate Cancer Cells
by: Ewelina Szliszka, et al.
Published: (2009-12-01) -
TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
by: Shihai Liu, et al.
Published: (2021-01-01) -
Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis
by: Yu Ren, et al.
Published: (2021-03-01)